Pancreatic cancer trial tests best time for chemo: before or after surgery?
NCT ID NCT04927780
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This phase 3 trial tests whether giving chemotherapy both before and after surgery helps people with pancreatic cancer live longer compared to chemotherapy only after surgery. About 378 patients with resectable pancreatic cancer will be randomly assigned to one of two treatment schedules. The goal is to find the best timing for chemotherapy to improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amphia Hospital
Breda, Netherlands
-
Amsterdam UMC
Amsterdam, Netherlands
-
Catharina Hospital
Eindhoven, Netherlands
-
Deventer Hospital
Deventer, Netherlands
-
Erasmus MC University Medical Center
Rotterdam, Netherlands
-
Isala Hospital
Zwolle, Netherlands
-
Jeroen Bosch Hospital
's-Hertogenbosch, Netherlands
-
Karolinska University Hospital
Stockholm, Sweden
-
Leiden University Medical Center
Leiden, Netherlands
-
Maasstad Ziekenhuis
Rotterdam, Netherlands
-
Maastricht UMC+
Maastricht, Netherlands
-
Meander Medical Center
Amersfoort, Netherlands
-
Medical Center Leeuwarden
Leeuwarden, Netherlands
-
Medisch Spectrum Twente
Enschede, Netherlands
-
OLVG
Amsterdam, Netherlands
-
Radboud University Medical Center
Nijmegen, Netherlands
-
Regional Academic Center Utrecht, Antonius Hospital
Utrecht, Netherlands
-
Sahlgrenska University Hospital
Gothenburg, Sweden
-
Skåne University Hospital
Lund, Sweden
-
Tjongerschans Hospital
Heerenveen, Netherlands
-
University Medical Center Groningen
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.